Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new terminology related to advanced cutaneous squamous cell carcinoma and the revision of the study version from v2.14.4 to v2.15.0. Notably, the names of collaborators and investigators have been retained, indicating continuity in the study's leadership.SummaryDifference19%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has been changed from March 25, 2025, to January 27, 2025.SummaryDifference0.4%
- Check38 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 27, 2025, and version 2.14.2.SummaryDifference0.3%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check81 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.